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Background: Despite an increase in the number of studies conducted in recent years
on human papillomavirus (HPV) and cervical cancer epidemiology, the proﬁle of multiple
HPV infections remain obscure, particularly among Chinese women. During 2004–2005,
a series of population-based HPV prevalence surveys were performed by Cancer Insti-
tute and Hospital of Chinese Academy of Medical Sciences (CIHCAMS) and International
Agency for Research on Cancer (IARC). Based on these surveys, we evaluated the preva-
lence and risk factors of multiple HPV infections, and explored its association with cervical
abnormalities among Chinese women.Methods:A total of 2374 women from three study
centers underwent gynecological examinations with valid cytology and their HPV results
were included in the analysis. Forty-four HPV types were detected using the GP5+/6+
PCR-based enzyme immunoassay. An unconditional logistic regression model was used
to evaluate the effect of multiple HPV infections on cervical lesions and its risk factors
adjusting for confounders.The between-groups difference was evaluated by a heterogene-
ity test based on the Q test. Results: One hundred and eleven women of multiple HPV
infections was found among 2374 Chinese women with a prevalence of 5.28% (95%
CI= 3.86–5.60%), which attributed to 28.98% (95% CI= 24.49–33.81%) of all of the 383
HPV-positive women. A signiﬁcantly increased risk of multiple HPV infections was found
in the older women (≥45 years; adjusted OR= 1.52, 95% CI= 1.02–2.27) and those having
more than three sexual partners (adjusted OR= 2.10, 95% CI= 1.05–4.17) after adjust-
ment for age-group, study area, and number of sexual partner. We also found that the
risk of high-grade lesions was signiﬁcantly higher than that of low-grade lesions with the
multiple HPV infections (Pheterogeneity = 0.044), but not as signiﬁcantly with the single HPV
infection (Pheterogeneity = 0.108). Conclusion:Multiple HPV Infections, especially with high-
risk HPV types, may be a substantial indicator either for public cervical cancer prevention
or clinical implications.
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INTRODUCTION
Epidemiological and laboratory-based studies have identiﬁed
that infection of high-risk human papillomavirus (HPV) as a
necessary but not sufﬁcient cause of cervical cancer (Munoz,
2000). More than 100 HPV genotypes have been fully char-
acterized on the basis of the isolation of complete genomes
present (IARC Working Group on the Evaluation of Carcino-
genic Risks to Humans, 2007). With the general improvement
in HPV DNA testing method, overall HPV prevalence in cer-
vical cancer increased signiﬁcantly from 85.9% in studies pub-
lished from 1990 to 1999 to 92.9% in studies published from
2006 to 2009, and the increases were large for the preva-
lence of multiple HPV infections (from 4.0 to 14.4%; Li et al.,
2011). Therefore, more and more evidences showed that the
occurrence of multiple infections is frequent as opposed to
occasional.
Due to the geographic variation of overall HPV prevalence,
occurrence also varied worldwide with a range of 0.4% in Spain
to 8.3% in Nigeria for multiple infections in cytologically normal
women (Clifford et al., 2005) and 4% in North America to 19%
in Africa in cervical cancer cases, respectively (de et al., 2010).
However, the reports focusing on the prevalence of multiple infec-
tions of HPV among Chinese women and its risk factors were rare.
Moreover, the association between multiple HPV infections and
cervical lesions remain unclear.
Therefore, we re-analyzed the data from three population-
based cross-sectional HPV prevalence surveys among Chinese
women performed in 2004–2005 to evaluate the prevalence and
its risk factors of multiple HPV infections, and explore the link
between the concurrent infection with multiple HPV types and
the cervical abnormalities in the certain population in the present
study.
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MATERIALS AND METHODS
STUDY SUBJECTS
Between 2004 and 2005, the Cancer Institute and Hospital, Chi-
nese Academy of Medical Sciences (CIHCAMS) and International
Agency for Research on Cancer (IARC) collaborated and per-
formed three population-based HPV prevalence surveys among
women in rural and urban areas of China, namely Yangcheng
County, Shanxi Province (Dai et al., 2006), Shenzhen City, Guang-
dong Province (Wu et al., 2007), and Shenyang City, Liaoning
Province (Li et al., 2006), respectively. Of these three study cen-
ters, Yangcheng County is a rural area of China, and the other two
centers are urban areas of China.
Details of the surveys have been reported previously. Brieﬂy,
women aged 15–59 years without pregnancies and hysterectomies
were enumerated. All participants signed an informed consent
form recommended by IARC and CIHCAMS ethical review
committees, which approved these three studies.
STUDY PROCEDURES
Study procedures were identical for these three study centers (Li
et al., 2009). To summarize, a standardized questionnaire inter-
view was administered to all participants by trained interviewers
in separated rooms to increase the compliance. Then the partici-
pants provided a sample of exfoliated cervical cell for liquid-based
cytology (LBC) and HPV testing and then underwent a clinical
examination including testing of visual inspection with acetic acid
(VIA), visual inspection with Lugol’s Iodine solution (VILI), and
digital colposcopy.
LABORATORY TEST
Liquid-based cytology was performed at CIHCAMS, Beijing,
China and the results were classiﬁed according to the Bethesda
System (Solomon et al., 2002). All abnormal smears, as well as
10% of normal smears chosen at random were reviewed by a sec-
ond experienced cytologist. HPV detection was performed in the
Department of Pathology at the Vrije University Medical Cen-
ter, Amsterdam, the Netherlands, using a GP5+/6+ PCR-based
enzyme immunoassay. Genotyping of 44 HPV types [HPV6, 11,
16, 18, 26, 30, 31, 32, 33, 34, 35, 39, 40, 42, 43, 44, 45, 51, 52,
53, 54, 55, 56, 57, 58, 59, 61, 64, 66, 67, 68, 69, 70, 71 (equiv-
alent to CP8061), 72, 73, 81 (equivalent to CP8304), 82 (IS39
and MM4 subtypes), 83 (equivalent to MM7), 84 (equivalent to
MM8), cand85, 86, cand89 (equivalent to CP6108), and JC9710]
was performed by reverse line blot hybridization of PCR prod-
ucts (van den Brule et al., 2002), and HPV types were classiﬁed,
for some analyses, into high- and low-risk types (Munoz et al.,
2003).
BIOPSIES TAKEN AND CERVICAL LESIONS ASSESSMENT
Cervical biopsies were prepared and read by a pathologist at
CIHCAMS, Beijing, China and the histological diagnosis were
made by two pathologists. Women with suspected abnormalities
found throughVIA,VILI,or colposcopyhad a colposcopy-directed
biopsy-taken and women whose entire squamocolumnar junction
could not be visualized underwent endocervical curettage (ECC).
In total, 515 women were take biopsies directly. Meanwhile, 54
women were underwent ECC with 28 cases of CIN1 or worse
histologically diagnosed.
When LBC results became available, all women with cytologi-
cally abnormal lesions (atypical squamous cells of undetermined
signiﬁcance,ASCUS or worse) not detected byVIA,VILI, or digital
colposcopy were recalled and had biopsies taken (Li et al., 2009).
Finally, 64.08% (91/142) women who should be called back visited
doctors again for biopsy-taken and 62 cases of CIN1 or worse were
histologically diagnosed.
Hence, in this study, cervical abnormalities were deﬁned as low-
grade lesions (including the presence of histologically conﬁrmed
cervical intraepithelial neoplasia 1 and cytologically conﬁrmed
low-grade lesion if histological results absent) or high-grade
lesions (including the presence of histologically conﬁrmed cervical
intraepithelial neoplasia 2 or worse and the cytologically con-
ﬁrmed high-grade lesion or worse if histological results absent).
On account of the performance of multiple screening tests and the
high proportion of histological conﬁrmation, women with nega-
tive diagnoses of all screening testswere considered as true negative
subjects. After combining the histological and cytological diagno-
sis results together, 109 (4.59%) and 66 (2.78%) cases of low- and
high-grade lesions were diagnosed, respectively.
STATISTICAL ANALYSIS
The prevalence of multiple HPV infections and its corresponding
95% conﬁdence interval (CI) were calculated. Pearson chi-square
test was used to evaluate the difference between multiple HPV
prevalence across studies. The statistical signiﬁcance of trends
for multiple HPV prevalence among different cervical lesions
was assessed by a non-parametric test, which was an extension
of the Wilcoxon rank-sum test. Odds ratios (ORs) and its cor-
responding 95% CI were used to evaluate the risk of cervical
lesionswithmultipleHPV infections and its risk factors (including
social-demographic characteristics, reproductive and menstrual
factors, sexual behaviors, etc.) by means of an unconditional logis-
tic regression model. A heterogeneity test was used to examine the
between-groups difference based on the χ2-based Q test and the
heterogeneity was considered signiﬁcant if P < 0.05. All analyses
were performed using the Stata statistical software (version 11.0,
StataCorp, College Station, TX, USA).
RESULTS
A total of 3504 women (941 from Yangcheng County, 1563 from
Shenzhen City, and 1000 from Shenyang City) participated in
the HPV prevalence surveys, among which 2374 women (662
from Yangcheng County, 1027 from Shenzhen City, and 685 from
Shenyang City) underwent gynecological examinations with valid
cytology and their HPV results were included in the analysis.
The mean age of the 2374 women was 38.50± 10.38 years,
varying between 35.19± 9.09 years in Shenzhen City and
41.16± 10.43 years in Shenyang City. The overall prevalence of
HPV infection ranged from 14.80% (95% CI = 12.18–17.74%)
in Yangcheng County to 16.79% (95% CI= 14.06–19.80%) in
Shenyang City (Figure 1). One hundred and eleven women
with multiple HPV infections were found among all the partic-
ipants. The prevalence of multiple HPV infections was 4.68%
(95% CI= 3.86–5.60%) with the highest prevalence in Shenyang
City (5.26%, 95% CI= 3.71–7.21%), followed by Yangcheng
County (4.54%, 95% CI= 3.08–6.41%), and Shenzhen City
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(4.38%, 95% CI= 3.21–5.82%), respectively (Figure 1). There
was no signiﬁcant difference in HPV prevalence among these
three centers either for HPV infection of any type (χ2 = 1.22,
P= 0.544) or multiple types (χ2 = 0.74, P= 0.689). Therefore,
we merged the data from these three centers for the further
analyses.
One hundred and eleven women with multiple HPV infections
attributed to 28.98%of all of the 383HPV-positivewomen, among
which 100 (90.09%) were infected with at least one high-risk type.
Most common patterns of multiple infections were concurrent
infections with two types, which accounted for 74.77% (83/111)
of all subjects with multiple HPV infections. With the increase of
age, there was no signiﬁcant increase of number of multiple HPV
infections (P for trend= 0.524, data not shown). However, though
there was also no signiﬁcant trend in the increase of number of
multiple HPV infections with the deterioration of cervical lesions
(P for trend= 0.927, data not shown), the prevalence of multi-
ple HPV infections increased with the severity of cervical lesions
(χ2 = 360.06, P< 0.001; Table 1).
FIGURE 1 | Prevalence of HPV infections among 2374 women, by study
center.
To further interpret the link between multiple HPV infec-
tions and cervical lesions, we did a comparison of the association
strength between the risk of cervical lesions and single and multi-
ple infections. The rate of single andmultiple infections by cervical
lesions were calculated by the formula of single or multiple HPV-
positive number divided by the HPV negative number in case
of the confoundings between single and multiple HPV infec-
tions (Table 2). It was certain that with the increase of severity
of cervical lesions, the prevalence of any HPV type increased.
Compared to women with normal cervixes, women with low-
grade cervical lesions, as well as women with high-grade lesions,
had a signiﬁcantly higher prevalence of both single (OR= 9.65,
95% CI= 6.26–14.87 and OR= 26.90, 95% CI= 13.27–54.51 for
low- and high-grade lesions, respectively) and multiple infec-
tions (OR= 9.40, 95% CI= 5.08–17.39 and OR= 62.76, 95%
CI= 29.70–132.62 for low- and high-grade lesions, respectively).
More interestingly, we also found that the OR values in the sub-
groups of high-grade lesions were signiﬁcantly higher than that
in the subgroups of low-grade lesions for multiple HPV infec-
tions (Pheterogeneity = 0.044), but not signiﬁcantly for single HPV
infection (Pheterogeneity = 0.108; Table 2).
To explore the implications of individual HPV types in mul-
tiple infections, we analyzed the prevalence of single and multi-
ple infections with the individual HPV types in cervical lesions.
Generally, HPV16 was by far the most common type with a mul-
tiple prevalence of 1.39% (95% CI= 0.96–1.95%), followed by
HPV58 (1.10%, 95% CI= 0.72–1.60%) and HPV52 (0.84%, 95%
CI= 0.52–1.30%), respectively (Table 3). After being stratiﬁed by
cervical lesions, we found that the prevalence ratio (PR) between
multiple and single infection was less than 1.00 for three HPV
types among women with cervical lesions (low-grade lesion or
worse), and, in the increasing order, were 0.52 for HPV16 and 0.90
for both HPV31 and HPV33. All the remaining HPV types were
more frequently found as a part of a multiple infection than a sin-
gle infection in the subgroup of cervical lesions presence with the
PR over than 1.00. As the representative of low-risk HPV types,
Table 1 | Occurrence of multiple infections of HPV by age-group, study area, and cervical lesion.
Characteristics 2Types no. (proportion, %) ≥3Types no. (proportion, %) Total
No. (prevalence, %) P
Total (n =2374) 83 (74.78) 28 (25.22) 111 (4.68) –
Age-group (years) 0.270
15–24 (n =197) 9 (81.82) 2 (18.18) 11 (5.58)
25–34 (n =769) 24 (75.00) 8 (25.00) 32 (4.16)
35–44 (n =686) 18 (72.00) 7 (28.00) 25 (3.64)
45–54 (n =514) 24 (80.00) 6 (20.00) 30 (5.84)
55–59 (n =208) 8 (61.54) 5 (38.46) 13 (6.25)
Study area 0.836
Rural (n =662) 24 (80.00) 6 (20.00) 30 (4.53)
Urban (n =1712) 59 (72.84) 22 (27.16) 81 (4.73)
Cervical lesions <0.001
Normal (n =2199) 53 (75.71) 17 (24.29) 70 (3.18)
Low-grade (n =109) 11 (68.75) 5 (31.25) 16 (14.68)
High-grade (n =66) 19 (76.00) 6 (24.00) 25 (37.88)
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Table 2 | Prevalence of single and multiple infections of HPV in cervical lesions.
Lesion
grade
Any-type infection Single infection Multiple infection
% (n+d/
n−e)
ORa (95% CI) Pheterogeneityc % (n+d/
n−e)
OR (95% CI) Pheterogeneity % (n+d/
n−e)
OR (95% CI) Pheterogeneity
Normal 12.1
(266/1933)
Ref.f 9.21
(196/1933)
Ref. 3.49
(70/1933)
Ref.
Low-
grade
56.88
(62/47)
9.59
(6.42–14.30)
49.46
(46/47)
9.65
(6.26–14.87)
25.40
(16/47)
9.40
(5.08–17.39)
High-
grade
83.33
(55/11)
36.33
(18.78–70.29)
0.044 73.17
(30/11)
26.90
(13.27–54.51)
0.108 69.44
(25/11)
62.76
(29.70–132.62)
0.044
aOR, odds ratio; b95% CI, 95% conﬁdence interval; cP values of heterogeneity test for ORs between-groups; dn+, number of HPV positivity; enumber of HPV
negativity; fRef., reference group.
HPV6 and 11 were absent from single infection among women
with cervical lesions (Table 3).
For the analysis of risk factors of multiple HPV infection, we
found thatwomenolder than 45 years (OR= 1.49,95%CI= 1.01–
2.22) and have had more than three sexual partners (OR= 2.11,
95% CI= 1.06–4.19) were associated with multiple HPV infec-
tions using a binary logistic regression. Results from multivariable
models also conﬁrmed that women older than 45 years (adjusted
OR= 1.52, 95% CI= 1.02–2.27) and have had more than three
sexual partners (adjusted OR= 2.10, 95% CI= 1.05–4.17) were
signiﬁcantly associated with multiple HPV infections after adjust-
ment for age-groups (<45 and ≥45 years), study areas (rural and
urban), and number of sexual partners (1, 2, and ≥3 sexual part-
ners;Table 4). In addition,we also revealed thatwith the increase of
number of sexual partners, the prevalence of multiple HPV infec-
tions signiﬁcantly increased (P for trend= 0.047; data not shown).
DISCUSSION
Since HPV prevalence varies across the geographic regions, it is
reasonable to postulate that the prevalence of multiple HPV infec-
tions is also heterogenic in different geographic regions. Based
on a series of population-based HPV prevalence surveys per-
formed by IARC all over the world with a standardized protocol,
it is easy and reliable for us to compare the multiple HPV infec-
tions among different geographic areas. In this population-based
multi-center cross-sectional study, we found that the prevalence
of multiple HPV infections among cytologically normal women
in China (3.18, 95% CI= 2.49–4.00%) was higher than that in
the other countries in Asia and Europe but lower than that in
South America and Sub-Saharan Africa (Clifford et al., 2005).
But the proportion (28.98% in our study) of the multiple HPV
infections among all HPV-positive Chinese women was similar to
other report (Mendez et al., 2005). The results revealed that the
co-infection with at least two types were frequent among Chinese
women other than occasional. We also found that there was no
association between number of HPV types and the presence of
cervical abnormalities, which was consistent with the results of a
cohort study performed in rural Costa Rica (Herrero et al., 2000).
The results suggested that the risk of cervical lesions may be more
associated with the combination of HPV subtypes as opposed to
the number of types. We also found that the prevalence of single
HPV infection was higher than that of multiple HPV infections
in women with cervical lesions for HPV16, 31, and 33. In addi-
tion, the single infection with low-risk HPV types was absent and
the prevalence of multiple infections with low-risk HPV types was
also very low in the women with cervical abnormalities, which
may suggest a stronger carcinogenesis for Alpha-9 Species of HPV
among the certain population, especially for HPV16, 31, and 33.
Age and sexual behavior were shown as the major risk factors
of multiple HPV infections among the certain population. In con-
trast to studies in some other areas, such as Denmark (Mejlhede
et al., 2009), older age was considered as a risk factor to multi-
ple infections in Chinese women. We should note that, differing
from the other areas with the peak of HPV prevalence in younger
women, China showed a ﬂat age-speciﬁc prevalence curve of any
HPV type (Franceschi et al., 2006). It implied a great possibil-
ity of the low rate of the clearance of HPV infection in Chinese
women compared towomen inEurope andNorthAmerica. There-
fore, due to the decrease of the immunity, the increase of multiple
HPV infection in older women was understandable. As we have
known, the most common mode of transmission of anogenital
HPV is by sexual activity. Many studies proved the association
between sexual behaviors and HPV prevalence. However, the rela-
tionship between sexual behaviors and multiple HPV infections
remains unclear. Our study showed that multiple sexual partners
was another risk factor of multiple HPV infection, and with the
increase of number of sexual partners, the prevalence of multiple
HPV infection increased (P for trend= 0.047). Considering the
low exposure to multiple sexual partners (5.67%, 95% CI= 4.00–
7.76% for ≥3 sexual partners) and the higher rate of multiple
HPV infection (6.77%, 95% CI = 4.94–9.01%) among the older
Chinese women, we may postulate that the occurrence of multiple
HPV infections among Chinese women is probably mainly due to
the accumulation of infections other than co-occurrence at one
time. Hence, the great probability of persistent infection among
Chinese women can explain the high incidence of cervical cancer
in China to an extent.
More interestingly, we observed that though multiple HPV
infection increased the risk of both low- and high-grade cer-
vical lesions, the risk of high-grade lesions was increased
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Table 4 | Characteristics related to multiple HPV infections among 2374 Chinese women.
Characteristics Multiple infections no. (%) Negative no. (%) ORa (95% CI)b Adjustedc OR (95% CI)
Age-group (years)
<45 68 (4.64) 1399 (95.36) Ref. Ref.
≥45 43 (6.77) 592 (93.23) 1.49 (1.01–2.22) 1.52 (1.02–2.27)
Area
Rural 30 (5.05) 564 (94.95) Ref. Ref.
Urban 81 (5.37) 1427 (94.63) 1.07 (0.69–1.64) 1.14 (0.74–1.76)
Education
≤Junior high school 51 (4.88) 994 (95.12) Ref. Ref.
≥Senior high school 60 (5.68) 997 (94.32) 1.17 (0.80–1.72) 1.43 (0.90–2.89)
Marriage times
1 105 (5.23) 1904 (94.77) Ref. Ref.
≥2 6 (6.45) 87 (93.55) 1.25 (0.53–2.93) 1.20 (0.51–2.83)
Age at menarche (years)
≤13 22 (3.61) 587 (96.39) Ref. Ref.
≥14 89 (5.96) 1404 (94.04) 1.69 (1.05–2.72) 1.60 (0.98–2.61)
Voluntary abortion times
1 33 (4.73) 664 (95.27) Ref. Ref.
2 16 (4.53) 337 (95.47) 0.95 (0.52–1.76) 0.91 (0.49–1.68)
≥3 8 (4.71) 162 (95.29) 0.99 (0.45–2.19) 0.92 (0.42–2.05)
Spontaneous abortions times
1 5 (3.27) 148 (96.73) Ref. Ref.
≥2 1 (3.33) 29 (96.67) 1.02 (0.11–9.06) 0.96 (0.10–8.82)
Live birth number
0 6 (5.04) 113 (94.96) Ref. Ref.
1 66 (5.27) 1187 (94.73) 1.05 (0.44–2.47) 0.91 (0.38–2.17)
2 20 (4.61) 414 (95.39) 0.91 (0.36–2.32) 0.62 (0.22–1.76)
≥3 10 (5.99) 157 (94.01) 1.20 (0.42–3.40) 0.66 (0.19–2.25)
Age at first delivery (years)
≤24 49 (5.07) 917 (94.93) Ref. Ref.
≥25 47 (5.32) 837 (94.68) 1.05 (0.70–1.59) 1.02 (0.62–1.67)
Condom use
No 59 (5.06) 1108 (94.94) Ref. Ref.
Yes 22 (2.44) 879 (97.56) 1.11 (0.76–1.63) 1.25 (0.78–1.99)
Number of sexual partners
1 88 (4.96) 1686 (95.04) Ref. Ref.
2 13 (5.73) 214 (94.27) 1.16 (0.64–2.12) 1.22 (0.67–2.22)
≥3 10 (9.90) 91 (90.10) 2.11 (1.06–4.19) 2.10 (1.05–4.17)
Age at first intercourse (years)
<20 20 (4.95) 384 (95.05) Ref. Ref.
≥20 91 (5.36) 1607 (94.64) 1.09 (0.66–1.79) 1.11 (0.63–1.98)
Husbands’ extra-marital intercourse
No 90 (5.18) 1646 (94.82) Ref. Ref.
Yes 16 (5.95) 253 (94.05) 1.16 (0.67–2.00) 1.18 (0.68–2.05)
aOR, odds ratio; b95% CI, 95% conﬁdence interval; cadjusted for age-groups, study areas, and number of sexual partners.
more signiﬁcantly than low-grade lesions (Pheterogeneity = 0.044).
But the pattern did not show for single HPV infection
(Pheterogeneity = 0.108). The results implied that multiple HPV
infections could be used as a substantial indicator to identify
the high-risk population in Chinese women either for public
prevention or clinical implication (Spinillo et al., 2009).
The main limitation of the study is the relatively small sam-
ple size, especially in stratiﬁed analyses. On the other hand, the
cross-sectional study design was less efﬁcient in demonstrating the
mechanism andnatural history of multipleHPV infections among
Chinese women clearly. Themulti-center large scale cohort studies
on the natural history of HPV infection will be very helpful in the
near future. However, as we know, it’s the ﬁrst time the proﬁle of
multiple HPV infections among Chinese women was provided.
The use of a standardized protocol and methodology in these
three study centers made the comparison and data combination
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reasonable and believable. From a practical viewpoint, the stud-
ies described the prevalence of multiple HPV infection among
women with or without cervical lesions, and its risk factors. The
ﬁndings of our study provide the basic and scientiﬁc data for the
introduction of vaccinations in China in the future.
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